Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Naloxone for Chronic Itch in Arsenic Exposure
NCT03751111Phase 2Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Feb 2019
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in chronic pruritus (CP), sponsored by Xiangya Hospital, Central South University. Started Feb 2019; status: completed.
02
Drugs
naloxone
03
Conditions
chronic pruritus (CP)
Beyond the preview
Go deeper on NCT03751111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751111.